Antimicrobial resistance among uropathogens that cause acute uncomplicated cystitis in women in Hong Kong: a prospective multicenter study in 2006 to 2008

Diagnostic Microbiology and Infectious Disease

Volumn 66, Issue 1, 2010, Pages 87-93

  Ho, Pak leung ^a   Yip, King Sun ^a   Chow, Kin Hung ^a   Lo, Janice Y C ^b   Que, Tak Lun ^c   Yuen, Kwok yung ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b DEPARTMENT OF HEALTH   (Hong Kong)

^c TUEN MUN HOSPITAL   (Hong Kong)

Author keywords

Co trimoxazole; Epidemiology; Escherichia coli; Fluoroquinolones

Indexed keywords

AMPICILLIN; CIPROFLOXACIN; COTRIMOXAZOLE; EXTENDED SPECTRUM BETA LACTAMASE; FOSFOMYCIN; NALIDIXIC ACID; NITROFURANTOIN;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CONTROLLED STUDY; CYSTITIS; ENTEROBACTERIACEAE; ESCHERICHIA COLI; FEMALE; GENETIC VARIABILITY; GRAM POSITIVE BACTERIUM; HONG KONG; HUMAN; MOLECULAR PHYLOGENY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; RISK FACTOR; STAPHYLOCOCCUS; URINE CULTURE;

EID: 71049128664     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2009.03.027     Document Type: Article

References (31)

1. American College of Obstetricians and Gynecologists. American College of Obstetricians and Gynecologists practice bulletin no. 91: treatment of urinary tract infections in nonpregnant women. Obstet. Gynecol. 111 (2008) 785-794
2. Calbo E., Romani V., Xercavins M., Gomez L., Vidal C.G., Quintana S., Vila J., and Garau J. Risk factors for community-onset urinary tract infections due to Escherichia coli harbouring extended-spectrum beta-lactamases. J. Antimicrob. Chemother. 57 (2006) 780-783
3. Centre for Health Protection. Antibiotic resistance patterns of bacteria isolated from urine specimens. Centre for Health Protection, Department of Health, Hong Kong (2008). http://www.chp.gov.hk Accessed on 19 January 2009
4. Christiaens T.C., De Meyere M., Verschraegen G., Peersman W., Heytens S., and De Maeseneer J.M. Randomised controlled trial of nitrofurantoin versus placebo in the treatment of uncomplicated urinary tract infection in adult women. Br. J. Gen. Pract. 52 (2002) 729-734
5. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: seventeenth informational supplement (2007), Clinical and Laboratory Standards Institute, Wayne (PA)
6. Duan R.S., Sit T.H., Wong S.S., Wong R.C., Chow K.H., Mak G.C., Yam W.C., Ng L.T., Yuen K.Y., and Ho P.L. Escherichia coli producing CTX-M beta-lactamases in food animals in Hong Kong. Microb. Drug Resist. 12 (2006) 145-148
7. Everett M.J., Jin Y.F., Ricci V., and Piddock L.J. Contributions of individual mechanisms to fluoroquinolone resistance in 36 Escherichia coli strains isolated from humans and animals. Antimicrob. Agents Chemother. 40 (1996) 2380-2386
8. Garau J. Other antimicrobials of interest in the era of extended-spectrum beta-lactamases: fosfomycin, nitrofurantoin and tigecycline. Clin. Microbiol. Infect. 14 Suppl. 1 (2008) 198-202
9. Grabe M., Bischop M.C., Bjerklund-Johansen T.E., Botto H., Cek M., Lobel B., Naber K.G., Palou J., and Tenke P. The management of urinary and male genital tract infections. European Association of Urology guidelines (2008). http://www.uroweb.org Accessed on 19 January 2009
10. Gupta K., Hooton T.M., Roberts P.L., and Stamm W.E. Short-course nitrofurantoin for the treatment of acute uncomplicated cystitis in women. Arch. Intern. Med. 167 (2007) 2207-2212
11. Ho P.L., Chow K.H., Yuen K.Y., Ng W.S., and Chau P.Y. Comparison of a novel, inhibitor-potentiated disc-diffusion test with other methods for the detection of extended-spectrum beta-lactamases in Escherichia coli and Klebsiella pneumoniae. J. Antimicrob. Chemother. 42 (1998) 49-54
12. Ho P.L., Tse W.S., Tsang K.W., Kwok T.K., Ng T.K., Cheng V.C., and Chan R.M. Risk factors for acquisition of levofloxacin-resistant Streptococcus pneumoniae: a case-control study. Clin. Infect. Dis. 32 (2001) 701-707
13. Ho P.L., Yung R.W., Tsang D.N., Que T.L., Ho M., Seto W.H., Ng T.K., Yam W.C., and Ng W.W. Increasing resistance of Streptococcus pneumoniae to fluoroquinolones: results of a Hong Kong multicentre study in 2000. J. Antimicrob. Chemother. 48 (2001) 659-665
14. Ho P.L., Chow K.H., Mak G.C., Tsang K.W., Lau Y.L., Ho A.Y., Lai E.L., and Chiu S.S. Decreased levofloxacin susceptibility in Haemophilus influenzae in children, Hong Kong. Emerg. Infect. Dis. 10 (2004) 1960-1962
15. Ho P.L., Shek R.H., Chow K.H., Duan R.S., Mak G.C., Lai E.L., Yam W.C., Tsang K.W., and Lai W.M. Detection and characterization of extended-spectrum beta-lactamases among bloodstream isolates of Enterobacter spp. in Hong Kong, 2000-2002. J. Antimicrob. Chemother. 55 (2005) 326-332
16. Ho P.L., Poon W.W., Loke S.L., Leung M.S., Chow K.H., Wong R.C., Yip K.S., Lai E.L., and Tsang K.W. Community emergence of CTX-M type extended-spectrum beta-lactamases among urinary Escherichia coli from women. J. Antimicrob. Chemother. 60 (2007) 140-144
17. Ho P.L., Wong R.C., Yip K.S., Loke S.L., Leung M.S., Mak G.C., Chow F.K., Tsang K.W., and Que T.L. Antimicrobial resistance in Escherichia coli outpatient urinary isolates from women: emerging multidrug resistance phenotypes. Diagn. Microbiol. Infect. Dis. 59 (2007) 439-445
18. Johnson J.R., Kuskowski M.A., O'Bryan T.T., and Maslow J.N. Epidemiological correlates of virulence genotype and phylogenetic background among Escherichia coli blood isolates from adults with diverse-source bacteremia. J. Infect. Dis. 185 (2002) 1439-1447
19. Karlowsky J.A., Kasloff S., Nichol K.A., Hoban D.J., and Zhanel G.G. Genetic relatedness of multidrug-resistant Escherichia coli cultured from geographically diverse outpatient, midstream urine specimens. Diagn. Microbiol. Infect. Dis. 58 (2007) 283-287
20. Kim M.E., Ha U.S., and Cho Y.H. Prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in female outpatients in South Korea: a multicentre study in 2006. Int. J. Antimicrob. Agents 31 Suppl. 1 (2008) S15-S18 Epub;%2007 Dec 21
21. Manges A.R., Tabor H., Tellis P., Vincent C., and Tellier P.P. Endemic and epidemic lineages of Escherichia coli that cause urinary tract infections. Emerg. Infect. Dis. 14 (2008) 1575-1583
22. Marcade G., Deschamps C., Boyd A., Gautier V., Picard B., Branger C., Denamur E., and Arlet G. Replicon typing of plasmids in Escherichia coli producing extended-spectrum beta-lactamases. J. Antimicrob. Chemother. 63 (2009) 67-71
23. Naber K.G., and Koch E.M. Cefuroxime axetil versus ofloxacin for short-term therapy of acute uncomplicated lower urinary tract infections in women. Infection 21 (1993) 34-39
24. Naber K.G., Schito G., Botto H., Palou J., and Mazzei T. Surveillance study in Europe and Brazil on clinical aspects and Antimicrobial Resistance Epidemiology in Females with Cystitis (ARESC): implications for empiric therapy. Eur. Urol. 54 (2008) 1164-1175
25. Patel S.S., Balfour J.A., and Bryson H.M. Fosfomycin tromethamine. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy as a single-dose oral treatment for acute uncomplicated lower urinary tract infections. Drugs 53 (1997) 637-656
26. Raz R., Chazan B., Kennes Y., Colodner R., Rottensterich E., Dan M., Lavi I., and Stamm W. Empiric use of trimethoprim-sulfamethoxazole (TMP-SMX) in the treatment of women with uncomplicated urinary tract infections, in a geographical area with a high prevalence of TMP-SMX-resistant uropathogens. Clin. Infect. Dis. 34 (2002) 1165-1169
27. Schito G.C. Why fosfomycin trometamol as first line therapy for uncomplicated UTI?. Int. J. Antimicrob. Agents 22 Suppl. 2 (2003) 79-83
28. Siu L.K., Ho P.L., Yuen K.Y., Wong S.S., and Chau P.Y. Transferable hyperproduction of TEM-1 beta-lactamase in Shigella flexneri due to a point mutation in the pribnow box. Antimicrob. Agents Chemother. 41 (1997) 468-470
29. Smith S.P., Manges A.R., and Riley L.W. Temporal changes in the prevalence of community-acquired antimicrobial-resistant urinary tract infection affected by Escherichia coli clonal group composition. Clin. Infect. Dis. 46 (2008) 689-695
30. Yilmaz E., Akalin H., Ozbey S., Kordan Y., Sinirtas M., Gurcuoglu E., Ozakin C., Heper Y., Mistik R., and Helvaci S. Risk factors in community-acquired/onset urinary tract infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae. J. Chemother. 20 (2008) 581-585
31. Zhanel G.G., Hisanaga T.L., Laing N.M., DeCorby M.R., Nichol K.A., Weshnoweski B., Johnson J., Noreddin A., Low D.E., Karlowsky J.A., and Hoban D.J. Antibiotic resistance in Escherichia coli outpatient urinary isolates: final results from the North American Urinary Tract Infection Collaborative Alliance (NAUTICA). Int. J. Antimicrob. Agents. 27 (2006) 468-475